Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,883 | 1,066 | 98.5% |
| Education | $266.61 | 19 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $2,357 | 132 | $0 (2023) |
| Novo Nordisk Inc | $2,265 | 128 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,098 | 118 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $1,902 | 117 | $0 (2023) |
| GlaxoSmithKline, LLC. | $1,260 | 92 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $1,167 | 67 | $0 (2023) |
| Lilly USA, LLC | $885.71 | 52 | $0 (2023) |
| Amgen Inc. | $865.82 | 53 | $0 (2022) |
| Merck Sharp & Dohme LLC | $552.68 | 41 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $513.20 | 30 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $2,236 | 120 | PFIZER INC. ($335.63) |
| 2022 | $2,242 | 111 | Boehringer Ingelheim Pharmaceuticals, Inc. ($367.94) |
| 2021 | $2,871 | 154 | Novo Nordisk Inc ($548.93) |
| 2020 | $2,089 | 127 | Novo Nordisk Inc ($305.09) |
| 2019 | $2,951 | 188 | PFIZER INC. ($389.55) |
| 2018 | $3,030 | 203 | PFIZER INC. ($478.76) |
| 2017 | $2,730 | 182 | PFIZER INC. ($428.25) |
All Payment Transactions
1,085 individual payment records from CMS Open Payments — Page 1 of 44
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Gastroenterology | ||||||
| 10/27/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: Oncology | ||||||
| 10/26/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Diabetes | ||||||
| 10/25/2023 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Diabetes | ||||||
| 10/24/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: DIABETES | ||||||
| 10/24/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $3.55 | General |
| Category: Respiratory | ||||||
| 10/18/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: RESPIRATORY | ||||||
| 10/18/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/12/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: VACCINES | ||||||
| 10/10/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/09/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Diabetes | ||||||
| 09/19/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: DIABETES | ||||||
| 09/15/2023 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Diabetes | ||||||
| 09/14/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug), LIVALO | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: PAIN MANAGEMENT | ||||||
| 09/13/2023 | Azurity Pharmaceuticals, Inc. | Edarbi (Drug) | Food and Beverage | Cash or cash equivalent | $16.83 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/12/2023 | Ultragenyx Pharmaceutical Inc. | — | Food and Beverage | In-kind items and services | $27.86 | General |
| 09/12/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: RESPIRATORY | ||||||
| 09/07/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: NEUROSCIENCE | ||||||
| 09/06/2023 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $3.40 | General |
| Category: VACCINES | ||||||
| 09/05/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $11.34 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/31/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: Diabetes | ||||||
| 08/28/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/23/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.00 | General |
| Category: Cardiovascular | ||||||
| 08/22/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/22/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 696 | 1,065 | $156,718 | $77,042 |
| 2022 | 8 | 594 | 1,139 | $134,449 | $70,835 |
| 2021 | 17 | 1,001 | 1,916 | $297,846 | $136,364 |
| 2020 | 21 | 1,476 | 2,376 | $344,092 | $140,382 |
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 199 | 323 | $70,664 | $30,308 | 42.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 248 | 488 | $64,344 | $29,348 | 45.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 114 | 114 | $17,100 | $15,258 | 89.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 80 | 80 | $3,200 | $1,522 | 47.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 26 | 27 | $1,080 | $328.59 | 30.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 29 | 33 | $330.00 | $277.20 | 84.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 310 | 778 | $94,244 | $54,262 | 57.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 121 | 144 | $26,802 | $10,688 | 39.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 29 | 29 | $5,190 | $3,985 | 76.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 14 | 14 | $1,244 | $579.93 | 46.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 45 | 48 | $2,802 | $541.03 | 19.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 20 | 20 | $800.00 | $384.38 | 48.0% |
| 85610 | Blood test, clotting time | Office | 2022 | 16 | 63 | $2,937 | $268.20 | 9.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 39 | 43 | $430.00 | $126.75 | 29.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 378 | 900 | $180,900 | $84,567 | 46.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 183 | 312 | $42,744 | $20,467 | 47.9% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 31 | 37 | $10,175 | $8,089 | 79.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 43 | 43 | $15,480 | $6,066 | 39.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 16 | 70 | $9,450 | $4,274 | 45.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 28 | 37 | $9,731 | $4,180 | 43.0% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 12 | 13 | $2,600 | $1,920 | 73.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 15 | 19 | $3,819 | $1,666 | 43.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 14 | 14 | $2,856 | $1,210 | 42.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 63 | 68 | $7,004 | $821.76 | 11.7% |
| 69210 | Removal of impact ear wax, one ear | Office | 2021 | 18 | 21 | $2,625 | $798.38 | 30.4% |
About Dr. David Levy, MD
Dr. David Levy, MD is a Family Medicine healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1437101714.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Levy, MD has received a total of $18,150 in payments from pharmaceutical and medical device companies, with $2,236 received in 2023. These payments were reported across 1,085 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($17,883).
As a Medicare-enrolled provider, Levy has provided services to 3,767 Medicare beneficiaries, totaling 6,496 services with total Medicare billing of $424,623. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Chicago, IL
- Active Since 05/16/2006
- Last Updated 04/27/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1437101714
Products in Payments
- JARDIANCE (Drug) $1,289
- XARELTO (Drug) $1,064
- ELIQUIS (Drug) $973.52
- TRELEGY ELLIPTA (Drug) $709.96
- FARXIGA (Drug) $693.71
- ENTRESTO (Drug) $513.20
- TRULICITY (Drug) $503.03
- Ozempic (Drug) $493.13
- CHANTIX (Drug) $402.45
- PREVNAR 20 (Biological) $371.89
- Aimovig (Biological) $325.97
- STIOLTO RESPIMAT (Drug) $324.44
- Tresiba (Drug) $321.70
- BREZTRI (Drug) $302.98
- Victoza (Drug) $301.84
- BPRO BT AMBULATORY BLOOD PRESSURE MONITORING SYSTEM (Device) $294.79
- SYMBICORT (Drug) $286.42
- BEVESPI AEROSPHERE (Drug) $283.86
- JANUVIA (Drug) $268.93
- MYRBETRIQ (Drug) $265.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Chicago
Dr. Bradley Torphy, M.d, M.D
Family Medicine — Payments: $1.3M
Dr. Sandy Gibson, D.o, D.O
Family Medicine — Payments: $252,793
Igor Altman, D.o, D.O
Family Medicine — Payments: $127,185
Ihab Aziz, Md, MD
Family Medicine — Payments: $65,230
Dr. Marla Kushner, Do, DO
Family Medicine — Payments: $31,849
Dr. Abdulmassih Abdulmassih, M.d, M.D
Family Medicine — Payments: $28,980